So. Jun 23rd, 2024

TechSci Research’s report titled “United States Women Health Laboratory Testing Market – By Region, Competition Forecast and Opportunities, 2018-2028″ predicts that the United States Women Health Laboratory Testing Market will experience an impressive Compound Annual Growth Rate (CAGR) during the forecast period of 2018-2028. This growth can be attributed to the increasing prevalence of chronic diseases, heightened awareness amongst key market players regarding various women’s health issues and the need for testing solutions, and recent developments. Moreover, technological advancements and research in developing new testing solutions to address various women’s health problems are expected to create lucrative opportunities for the growth of the United States Women Health Laboratory Testing Market in the coming years.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “United States Women Health Laboratory Testing Market”- https://www.techsciresearch.com/report/united-states-women-health-laboratory-testing-market/14827.html

The United States Women Health Laboratory Testing Market can be segmented by hereditary cancer, reproductive health and infectious diseases, prenatal screening and diagnostic testing, region, and competitive landscape. In terms of hereditary cancer, the market is segmented into cervical cancer, ovarian cancer, and breast cancer. The cervical cancer segment is expected to exhibit significant growth during the forecast period due to the rising incidence of this type of cancer among women. With respect to reproductive health and infectious diseases, the market can be categorized into CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, and HPV Testing.

The HIV Testing segment is expected to display impressive growth during the forecast period due to the increasing rate of AIDS in the population. Additionally, the growing incidence of human papillomavirus in the country is expected to create new opportunities for the growth of the HPV testing segment in the coming years. According to the Centers for Disease Control and Prevention, more than 42 million Americans are infected with types of HPV that cause disease. Regionally, the market is divided into the Mid-West, South, North-East, and West. The Mid-West region is expected to exhibit significant growth during the forecast period due to advanced healthcare facilities and growing expenditure in research and development in the region.

Major companies operating in United States Women Health Laboratory Testing Market include:

  • F. Hoffmann-La Roche AG.
  • Stanbio Laboratory L.P.
  • Yourgene Health
  • Myriad Genetics Inc.
  • Natera, Inc.
  • Ovia Health
  • Laboratory Corporation of America Holdings, Inc.
  • Gateway Genomics, LLC
  • Ascension Healthcare Network Inc
  • EKF Diagnostics Holdings Plc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“United States Women Health Laboratory Testing Market is expected to witness significant growth during the forecast period on account of increasing awareness for diagnostic procedures. An increase in number of cancer and chronic diseases further supports the demand for women health laboratory testing market in the United States. Additionally, increase in emergence of players developing new procedures of diagnostic and treatment is expected to create lucrative opportunities for the market growth in the next few years” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.

“United States Women Health Laboratory Testing Market By Hereditary Cancer (Cervical Cancer, Ovarian Cancer, Breast Cancer), By Reproductive Health and Infectious Diseases (CT/NG Testing, Preimplantation Genetic Testing (PGT), Herpes Simplex Virus (HSV), Hepatitis, Sexually Transmitted Infections, Vaginal Infections, PAP Smear Testing, HIV Testing, Pregnancy and Ovulation Testing, HPV Testing), By Prenatal Screening and Diagnostic Testing (Non-Invasive Prenatal Testing (NIPT), Maternal Serum Screening (MSS), Prenatal Diagnostic Testing), By Region, Competition Forecast & Opportunities, 2018-2028”, has evaluated the future growth potential of United States Women Health Laboratory Testing Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States Women Health Laboratory Testing Market.

Download Free Sample Report- https://www.techsciresearch.com/sample-report.aspx?cid=14827

Related Reports:

United states hereditary genetic testing market

Ent devices market

United states women health laboratory testing market

Wound treatment market

About TechSci Research:

TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Web: https://www.techsciresearch.com

Pressemitteilung teilen:

Schreibe einen Kommentar